Accessibility navigation

Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors

Neuman, B. W., Bederka, L. H., Stein, D. A., Ting, J. P. C., Moulton, H. M. and Buchmeier, M. J. (2011) Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors. Antimicrobial Agents and Chemotherapy, 55 (10). pp. 4631-4638. ISSN 1098-6596

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1128/AAC.00650-11


Members of the Arenaviridae are a threat to public health and can cause meningitis and hemorrhagic fever, yet treatment options remain limited by a lack of effective antivirals. In this study, we found that peptide-conjugated phosphorodiamidate morpholino oligomers (PPMO) complementary to viral genomic RNA were effective in reducing arenavirus replication in cell cultures and in vivo. PPMO complementary to the Junín virus genome were designed to interfere with viral RNA synthesis, translation, or both. However, only PPMO designed to potentially interfere with translation were effective in reducing virus replication. PPMO complementary to sequence that is highly conserved across arenaviruses and located at the 5’-termini of both genomic segments were effective against Junín, Tacaribe, Pichinde and Lymphocytic Choriomeningitis arenavirus-infected cell cultures, and suppressed viral titers in the livers of LCMV-infected mice. These results suggest that arenavirus 5’-genomic-termini represent promising targets for pan-arenavirus antiviral therapeutic development.

Item Type:Article
Divisions:Life Sciences > School of Biological Sciences > Biomedical Sciences
ID Code:23408
Uncontrolled Keywords:Arenavirus, LCMV, morpholino, antisense, antiviral
Publisher:ASM Press

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation